Dr Ngwa is the Director of Global Health Catalyst (GHC) at Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School. The GHC is dedicated to catalyzing high impact international collaborations to eliminate global health disparities in cancer and related diseases. This cutting-edge work is helping shape the emerging field of global radiation oncology and has led to many collaborations in global oncology research, education and care involving USA and African Institutions. Besides directing the GHC, Dr Ngwa's work integrates research, clinical service, and teaching, with current research focus on developing more accessible and effective technologies/approaches for cancer cure including the development of smart radiotherapy biomaterials (Tiny drones to Target cancer) designed to boost local and metastatic tumor cell kill with minimal collateral damage or side effects. The Award-winning drone technology is adaptable to delivering different drug payloads precisely to disease sites or targets, including immunotherapy drugs and cannabinoids, with greater therapeutic efficacy and minimal or no toxicities.